[Edaily Reporter SHIN MIN JOON ] Neopharm CO., LTD.(092730), a South Korean derma-beauty specialist, is seeking to expand into a global derma-beauty brand by leveraging “Atopam,” a skincare brand specializing in sensitive skin conditions such as atopic dermatitis (eczema).

To this end, Neopharm CO., LTD. is also developing new brands alongside Atopam, including Real Barrier (moisturizing cream), a dermocosmetic brand specializing in the skin barrier; Derma B (body lotion and Wish), a daily moisturizing body care brand; and Zeroid, a medical skincare brand. In addition, Neopharm CO., LTD. is actively targeting overseas markets such as the United States, China, and Japan.

According to the derma-beauty industry on the 8th, Neopharm CO., LTD.’s revenue and operating profit for the first half of this year reached 79.8 billion won and 18.5 billion won, respectively. Revenue and operating profit increased by 25.5% and 25%, respectively, compared to the same period last year. If the current trend continues, Neopharm CO., LTD. is likely to set a new all-time record this year. Last year, Neopharm CO., LTD. posted revenue of 132.2 billion won and operating profit of 28.8 billion won. Both revenue and operating profit reached record highs last year.

The reason Neopharm CO., LTD. continues to set new records is the growth of its flagship brand, Atopalm, as well as newly developed brands such as Real Barrier, Derma B, and Zeroid. The fact that derma-beauty products are supplied to hospitals and clinics—which creates high barriers to entry—also plays a significant role.

Neopharm CO., LTD. also possesses unparalleled skin barrier technology. The company highlights MLE (Multi-Lamellar Emulsion)—a proprietary formulation technology that replicates the lipid structure of healthy skin—as its core competitive advantage. MLE is an oil-in-water emulsion in which oil is dispersed in the form of extremely small droplets within water, forming a multi-lamellar structure with dozens or more layers of emulsion membranes.

By forming this multi-layered structure, MLE helps defend against the penetration of microorganisms and allergens (substances that trigger allergic reactions), thereby normalizing the skin barrier and restoring the skin’s moisture content to an optimal level. Based on this technological expertise, Atopam has ranked first for 20 consecutive years—from 2007 to the present—in the Sensitive Skin Care category of the Korea Brand Power Index (K-BPI).

Neopharm CO., LTD. is stepping up its efforts to penetrate overseas markets. With brands such as AtoPharm having been thoroughly validated in the domestic market, the company is now seeking to expand into a global brand. As of June of this year, exports accounted for only about 20% of Neopharm CO., LTD.’s total sales.

In particular, Neopharm CO., LTD. is focusing its efforts on the U.S. market, the world’s largest beauty market. The company is expanding its presence through local distribution channels such as Amazon and TikTok Shop. As a result, sales in the U.S. (North America) last year increased by 109% compared to the previous year. During this year’s Amazon Prime Day, Neopharm CO., LTD.’s Atopalm, DermaV, and Zeroid brands all recorded sales growth rates of over 100% compared to the previous year.

Neopharm CO., LTD. is also focusing on technology-driven marketing—such as securing clinical data and making academic presentations—rather than advertising-centric approaches. As a company specializing in derma-beauty, Neopharm CO., LTD. is emphasizing its expertise by targeting consumers with skin conditions and sensitive skin. Neopharm CO., LTD. is also pursuing expansion into Japan and China. In line with the expansion of its new brands, Neopharm CO., LTD. has increased its annual production capacity this year from 21,508,000 units to 27,528,000 units.

A Neopharm CO., LTD. official stated, “While Neopharm CO., LTD. is centered on derma-beauty brands, we are segmenting our product lineup—such as with Zeroid—to target the MZ generation in order to expand our customer base,” adding, “Neopharm CO., LTD. is striving to expand as a global derma-beauty brand, as evidenced by our signing of SEVENTEEN’s Joshua as the advertising model for Real Barrier.”